Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma
- 1 December 2017
- journal article
- conference paper
- Published by Elsevier in Cancer Letters
- Vol. 410, 20-31
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinomaBMC Cancer, 2012
- Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humansHepatology, 2012
- Review of the Y chromosome, Sry and hypertensionSteroids, 2010
- Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammalBMC Biology, 2010
- Conditional β-Catenin Loss in Mice Promotes Chemical Hepatocarcinogenesis: Role of Oxidative Stress and Platelet-Derived Growth Factor Receptor α/Phosphoinositide 3-Kinase Signaling†Hepatology, 2010
- Sex Differences in the Expression of Hepatic Drug Metabolizing EnzymesMolecular Pharmacology, 2009
- Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor αexpressionDevelopment, 2008
- Molecular characterization of senescence marker protein-30 gene promoter: Identification of repressor elements and functional nuclear factor binding sitesBMC Molecular Biology, 2008
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- SOX9 directly regulates the type-ll collagen geneNature Genetics, 1997